Valvular Heart Disease in Heart Failure with Preserved Ejection Fraction
Open Access
- 27 May 2026
- journal article
- review article
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 12, e14
Abstract
Heart failure with preserved ejection fraction (HFpEF) is associated with reduced functional capacity and quality of life, as well as with high rates of heart failure hospitalisation and mortality. Valvular heart disease (VHD) is frequently encountered in patients with HFpEF, and both conditions share common risk factors, such as age, hypertension, diabetes and coronary artery disease, which may contribute to their shared pathogenesis and progression. With recent advances in percutaneous therapies for VHD and an improved understanding of HFpEF, there is a growing interest in the relationship between VHD and HFpEF. In this review, we provide an overview of the pathophysiology, epidemiology and management strategies of tricuspid regurgitation, mitral regurgitation, aortic stenosis and aortic regurgitation in the setting of HFpEF.Keywords
This publication has 84 references indexed in Scilit:
- Cause-Specific Death in Heart Failure Across the Ejection Fraction Spectrum: A Comprehensive Assessment of Over 100 000 Patients in the Swedish Heart Failure RegistryEuropean Journal of Heart Failure, 2024
- Long-Term Prognostic Value of the H2FPEF Score in Patients Undergoing Transcatheter Aortic Valve ImplantationESC Heart Failure, 2024
- Mitral Regurgitation in Heart Failure with Preserved Ejection Fraction: The Interplay of Valve, Ventricle, and AtriumEuropean Journal of Heart Failure, 2024
- Haemodynamic and Metabolic Phenotyping of Patients with Aortic Stenosis and Preserved Ejection Fraction: A Specific Phenotype of Heart Failure with Preserved Ejection Fraction?European Journal of Heart Failure, 2023
- Prevalence, Clinical Characteristics and Outcomes of Heart Failure Patients with or Without Isolated or Combined Mitral and Tricuspid Regurgitation: An Analysis from the ESC-HFA Heart Failure Long-Term RegistryEuropean Journal of Heart Failure, 2023
- Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term RegistryEuropean Journal of Heart Failure, 2023
- Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS‐HFpEF studyEuropean Journal of Heart Failure, 2022
- Characterization of the Inflammatory-Metabolic Phenotype of Heart Failure with a Preserved Ejection Fraction: A Hypothesis to Explain Influence of Sex on the Evolution and Potential Treatment of the DiseaseEuropean Journal of Heart Failure, 2020
- Functional Mitral Regurgitation and Left Atrial Myopathy in Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure, 2020
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection FractionJAMA, 2013